Medical Imaging Phantoms Market: Market Size & Forecast 2026

Medical imaging phantoms serve as physical or digital reference standards that simulate human tissue properties, enabling healthcare providers to ensure imaging systems produce accurate, consistent, and diagnostically reliable results. These devices are essential for routine quality assurance, equipment commissioning, and staff training across modalities including MRI, CT, PET, ultrasound, and X-ray. The global market sits at approximately $0.2 billion in 2025, with independent industry estimates ranging from $178.64 million to $228.8 million depending on the scope of products included.

• •Phantoms support quality assurance and regulatory compliance for clinical imaging equipment
• •Scope includes MRI, CT, ultrasound, X-ray, nuclear medicine, and other modality-specific test objects
• •Market size estimates in 2025 vary across research firms from roughly $179 million to $229 million

Rising demand for diagnostic imaging services, fueled by aging populations and growing prevalence of chronic diseases, is expanding the installed base of imaging equipment that requires ongoing calibration and quality assurance using phantoms. Stringent regulatory standards from bodies such as the FDA and the European Union mandate regular equipment performance verification, creating sustained demand for phantom products and replacement consumables. Additionally, technological advances in imaging systems, including AI-enhanced scanners and higher-resolution modalities, are driving demand for more sophisticated and modality-specific phantom designs.

• •Aging populations and rising disease burden are increasing diagnostic imaging volumes globally
• •Regulatory mandates for quality assurance and accreditation programs sustain replacement and upgrade demand
• •Advances in imaging technology require more advanced and specialized phantoms for calibration

The market is commonly segmented by product type, including MRI phantoms, CT phantoms, ultrasound phantoms, X-ray phantoms, and nuclear medicine phantoms, with MRI and CT phantoms typically representing the largest segments due to the widespread adoption of these modalities. By end user, hospitals dominate demand, followed by diagnostic imaging centers, research institutions, and original equipment manufacturers for factory testing. North America, particularly the United States, leads the market, supported by advanced healthcare infrastructure, high imaging equipment density, and rigorous quality standards, while Europe and Asia-Pacific represent significant and fast-growing regional markets.

• •The U.S. market alone is forecast at roughly $70 million by 2030, growing at approximately 5.7% annually
• •MRI and CT phantoms account for the largest product segments given the prevalence of these modalities
• •Hospitals and imaging centers are the primary end users, with OEMs representing a notable niche segment

What are the recent trends and outlook?

The market is expected to maintain a compound annual growth rate in the range of 4% to 6% through 2030 to 2035, depending on the source, with the broader diagnostic imaging market projected to reach approximately $32.9 billion by 2030. Key trends include increasing adoption of 3D-printed and customizable phantoms for research and specialized applications, integration with digital quality assurance workflows and cloud-based tracking systems, and growing demand in emerging markets as healthcare infrastructure expands. The parent diagnostic imaging market, valued at approximately $26.51 billion in 2025, provides a strong macro context for sustained phantom demand.

• •Long-term forecasts project the market reaching roughly $256 million to $339 million between 2030 and 2035
• •3D-printed and customizable phantoms are emerging as a notable product innovation area
• •Emerging market expansion and digital QA integration represent near-term growth opportunities